0000899866-17-000161.txt : 20170905
0000899866-17-000161.hdr.sgml : 20170905
20170905192816
ACCESSION NUMBER: 0000899866-17-000161
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170831
FILED AS OF DATE: 20170905
DATE AS OF CHANGE: 20170905
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Neill Julie
CENTRAL INDEX KEY: 0001630299
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27756
FILM NUMBER: 171069966
MAIL ADDRESS:
STREET 1: C/O ALEXION PHARMACEUTICALS
STREET 2: 352 KNOTTER DRIVE
CITY: CHESHIRE
STATE: CT
ZIP: 06410
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000899866
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133648318
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 COLLEGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 2032722596
MAIL ADDRESS:
STREET 1: 100 COLLEGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
wf-form4_150465408293648.xml
FORM 4
X0306
4
2017-08-31
0
0000899866
ALEXION PHARMACEUTICALS INC
ALXN
0001630299
O'Neill Julie
C/O ALEXION PHARMACEUTICALS, INC
100 COLLEGE STREET
NEW HAVEN
CT
06510
0
1
0
0
EVP. Global Operations
Common Stock, par value $.0001 per share
2017-08-31
4
S
0
612
142
D
26092
D
Common Stock, par value $.0001 per share
2017-09-05
4
S
0
1841
145.81
D
24251
D
Common Stock, par value $.0001 per share
2017-09-05
4
S
0
672
147
D
23579
D
Common Stock, par value $.0001 per share
2017-09-05
4
S
0
600
145.64
D
22979
D
Common Stock, par value $.0001 per share
2017-09-05
4
S
0
650
145.81
D
22329
D
The transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $142.00 - $142.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $145.51 - $146.51. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
/s/ Michael Greco, Attorney-in-Fact for Julie O'Neill
2017-09-05